胺作为一种心理健康治疗方法
1Liz Braun is a psychiatric-mental health NP who is working on her PhD in nursing ethics and Alison Colbert is a professor at the Duquesne University School of Nursing in Pittsburgh, PA. Contact author: Liz Braun, braune@duq.edu. The authors discuss certain off-label uses of ketamine in the treatment of mental health disorders. The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
胺对抗治疗的精神健康障碍,如抑郁症,显示出有前途. 这篇文章回顾了其临床使用,不断发展的证据,以及护理对患者护理的影响.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胺是1970年批准的麻醉剂.
- 它越来越多地用于精神健康障碍的非标签,在2019年批准用于治疗耐药抑郁症.
- 现有的治疗方法有局限性,因此需要新的干预措施.
研究的目的:
- 为护士提供关于胺胺用于心理健康治疗的必要临床信息.
- 讨论胺治疗的不断变化的证据和监管格局.
- 探索基他胺在心理健康中的使用对伦理和护理的影响.
主要方法:
- 关于胺胺的有效性和管理的当前文献的综述.
- 对监管状况和临床应用的分析 (IV,鼻内,心理治疗).
- 讨论伦理考虑和护理责任.
主要成果:
- 氨酸为治疗耐药性疾病提供了一种新的作用机制.
- 存在各种各样的施用方法,包括鼻内胺,静脉注射和胺辅助心理治疗.
- 监管框架和证据库仍在发展.
结论:
- 护士需要全面的知识来建议患者进行胺治疗.
- 分散的监管和不断变化的证据需要谨慎的患者管理.
- 胺代表了在心理健康治疗方面显著的,尽管复杂的进步.
更多相关视频
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
相关概念视频
Electroconvulsive Therapy
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Sedatives and Hypnotics Drugs: Barbiturates
